Interest Income Expense - CG Oncology Inc (NASDAQ:CGON) - Alpha Spread
C

CG Oncology Inc
NASDAQ:CGON

Watchlist Manager
CG Oncology Inc
NASDAQ:CGON
Watchlist
Price: 39 USD -0.28% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
CG Oncology Inc?
Write Note

CG Oncology Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CG Oncology Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
C
CG Oncology Inc
NASDAQ:CGON
Interest Income Expense
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
10%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$1.1B
CAGR 3-Years
29%
CAGR 5-Years
-12%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$3.9B
CAGR 3-Years
-61%
CAGR 5-Years
-41%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$621.3m
CAGR 3-Years
315%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$697.5m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CG Oncology Inc's Interest Income Expense?
Interest Income Expense
6.9m USD

Based on the financial report for Dec 31, 2023, CG Oncology Inc's Interest Income Expense amounts to 6.9m USD.

Back to Top